Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center. - Wikidata - wikimedia - TriplyDB

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

http://www.wikidata.org/entity/Q36064946

about

The possibility of clinical sequencing in the management of cancer An NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology.Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers.Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Effective quality management practices in routine clinical next-generation sequencing.Changing paradigm of cancer therapy: precision medicine by next-generation sequencing.Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.Clinical Genotyping of Non-Small Cell Lung Cancers Using Targeted Next-Generation Sequencing: Utility of Identifying Rare and Co-mutations in Oncogenic Driver Genes.Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.Immunogenomics: using genomics to personalize cancer immunotherapy.Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast Cancer.Massive parallel sequencing of solid tumours - challenges and opportunities for pathologists.Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.Implementation and utilization of the molecular tumor board to guide precision medicine.PRECISION ONCOLOGY DECISION SUPPORT: CURRENT APPROACHES AND STRATEGIES FOR THE FUTURE.Trailblazing Precision Oncology for Rare Tumor Subtypes.The rise of genomic profiling in ovarian cancer.Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification.

P2860

Q28072144-D4578B65-F4CF-440B-B1A0-B421597F2A12 Q31077769-A97DFD41-FCB8-4A93-B3D8-ADBF5186F035 Q33677392-6B32D257-2CD5-4F20-896A-26D4673C7070 Q33685000-C2C3A1ED-DEEE-4B14-81B7-D85A8AFE48F6 Q33688966-E0D02B46-9A09-492A-93BB-C5E272EA0212 Q33873653-B70A5DCD-9E1A-42CB-9597-87E0C7C5C6A2 Q34550417-D210E1CD-D210-499D-8CFD-8BE40749B37C Q35922622-F792515D-45DF-4576-8A1A-390438FD19CE Q36849642-421E85B9-37B1-4AFD-96A2-ADCA787B2653 Q37269473-EB69C047-DE69-4417-9692-194851DF2BC5 Q37273873-E30E8EB7-FF4B-4541-8582-5EDD884AD599 Q38759643-BDD7DB5C-739F-40B7-84E4-11A9C0AE188C Q38772744-3ABDF607-62C6-4806-BA27-8024256A4738 Q38825945-3BB58EB1-C25F-4EAE-9A7D-589372049B95 Q38828314-E4B0D5B3-2035-4494-9A7D-6F1684A1408B Q39888234-54336AA2-E9E6-4462-BC96-E7F3A31E4C48 Q41339458-C50355D7-6B0E-4D35-9415-ED171C7944D3 Q50115884-8C9AD661-C744-47E9-A6D7-4FAAEEDFD2B4 Q50147657-0A657900-F8CF-438A-88B6-BD5F6CCB0410 Q50345037-6F4BFB53-497B-45D7-86C5-D29E97262C2C Q55178886-D136DE6A-263F-4A3F-B464-64FF65DD7D14

P2860

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

http://www.wikidata.org/entity/Q36064946

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Implementation of a Molecular ...... outh-Hitchcock Medical Center.

@ast

Implementation of a Molecular ...... outh-Hitchcock Medical Center.

@en

type

label

Implementation of a Molecular ...... outh-Hitchcock Medical Center.

@ast

Implementation of a Molecular ...... outh-Hitchcock Medical Center.

@en

prefLabel

Implementation of a Molecular ...... outh-Hitchcock Medical Center.

@ast

Implementation of a Molecular ...... outh-Hitchcock Medical Center.

@en

P1433

Q36064946-E55FC6A6-33D9-4737-A79E-508C0086BEA2

P1476

Q36064946-E84C7A27-6492-42FE-95AE-A3A7901E429D

P2093

Q36064946-03F13AAC-5C48-4FA2-BEA3-AFE848CE9D5D

Q36064946-0CC0D25C-E715-4960-ABFD-B8BF396B8603

Q36064946-176DCDEB-120B-484B-8394-EF4997B56F8C

Q36064946-32CA64EE-A4BE-4A55-AF8B-C1EF5F72B09C

Q36064946-5972717E-DA67-4713-9201-2501524FF998

Q36064946-5B37BEDE-4008-4FB6-A40B-FADBD4B37C1F

Q36064946-67AD00EA-A4A5-46E5-BAEF-9783E0B07056

Q36064946-82D1257D-5359-48F0-B325-C97329B3C28E

Q36064946-89DDBE60-EC8B-479C-9A1D-6990AE13692F

Q36064946-8F57F8C3-8A75-4D99-ABA0-7A563CD3A37C

P2860

Q36064946-0AD12E4D-D9DE-4BD1-86E2-04B4B2640EAA

Q36064946-325721F8-E558-44BB-A91C-8E1E119B8A06

Q36064946-328B0477-EF77-49E2-A568-42515325F555

Q36064946-3595B174-3242-4938-9A70-6311B1317793

Q36064946-38B6EF3A-A491-4E57-ADD1-5311B9FD413B

Q36064946-3C0B5A3D-20B4-4A17-88FD-F2CC09DC899D

Q36064946-4C282C8C-A421-49BD-8D6B-5BC9107A72A4

Q36064946-5077723D-205E-4A96-AB37-89484978E6E2

Q36064946-586C5356-7B24-4BED-9C0F-8078087A0F4C

Q36064946-5C3CF84A-2996-43A1-A62C-06F38B1646AF

P304

Q36064946-41573D0A-BBCC-454B-8EE9-C2AAA015B07C

P31

Q36064946-8408401B-F40C-4ABE-9BA3-40353658FA04

P356

Q36064946-EDF8DD08-3698-4E92-ACB5-FB23487F3BB3

P433

Q36064946-4097E42D-26D8-4D6D-A8AA-D08D077543BE

P478

Q36064946-31D7031A-0C5D-4228-852E-89E943CFE97C

P50

Q36064946-78A95243-8A74-4E0C-8E25-4E079B2BAA00

P577

Q36064946-ABB4A06F-FF7F-4565-AC56-0CF7AC0A6477

P698

Q36064946-18BD39F1-ABFE-4644-887B-250954129AE0

P932

Q36064946-9D284DEB-7DAA-4D58-A7BF-66AA1546A213

P356

THEONCOLOGIST.2015-0097

P1433

P1476

Implementation of a Molecular ...... outh-Hitchcock Medical Center.

@en

P2093

Arief A Suriawinata

http://www.w3.org/2001/XMLSchema#string

Britt M Holderness

http://www.w3.org/2001/XMLSchema#string

Camilo E Fadul

http://www.w3.org/2001/XMLSchema#string

Clinton R Morgan

http://www.w3.org/2001/XMLSchema#string

Francine B de Abreu

http://www.w3.org/2001/XMLSchema#string

Gary N Schwartz

http://www.w3.org/2001/XMLSchema#string

Gregory J Tsongalis

http://www.w3.org/2001/XMLSchema#string

Ivan P Gorlov

http://www.w3.org/2001/XMLSchema#string

Jason D Peterson

http://www.w3.org/2001/XMLSchema#string

Jason R Pettus

http://www.w3.org/2001/XMLSchema#string

P2860

Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors

dbSNP: the NCBI database of genetic variation

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

Response and acquired resistance to everolimus in anaplastic thyroid cancer

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

The frequency of Muir-Torre syndrome among Lynch syndrome families

Update on activities at the Universal Protein Resource (UniProt) in 2013

SNP arrays: comparing diagnostic yields for four platforms in children with developmental delay.

Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2

P304

1011-1018

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2015-0097

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Joel A Lefferts

P577

2015-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26205736

http://www.w3.org/2001/XMLSchema#string

P932

4571816

http://www.w3.org/2001/XMLSchema#string